The UCL Cancer Institute is uniquely placed to leverage the multidisciplinary nature of UCL by engaging a range of disciplines to transform cancer research and cancer treatment.
The UCL CAR T programme
The UCL CAR T-cell programme is the most comprehensive in Europe. We lead a broad-ranging portfolio of studies, actively recruiting patients with B and T-cell malignancies, myeloma, and neuroblastoma.
Our Research in Oncology
- Antibody Based Medicines
- Applied Brain Cancer Biology
- Brain Vascular Biology and Brain Cancer Biology
- Cancer Drug Development
- Cancer Evolution and Genome Instability
- Cancer Genome Evolution
- Cancer Metastasis
- Cell Communication
- Cell Signalling
- Computational Cancer Genomics
- CRUK Drug-DNA Interactions
- Glioblastoma
- Head and Neck Cancers
- Samantha Dickson Brain Cancer Unit
- Treatment Resistance
- Tumour ImmunoGenomics and Immunosurveillance
- Urological Cancer Biology
£8million funding boost to accelerate brain tumour research
The CRUK Glioma Centre of Excellence, a joint initiative between UCL and the University of Edinburgh, is researching how glioblastoma starts, evolves, and evades existing treatments.
Clinical Trials
Department of Clinical Trials
The Cancer Research UK and UCL Cancer Trials Centre forms the Clinical Trials research department within UCL Cancer Institute and is part of the Cancer Research UK-UCL Centre.
No. 1 We are ranked first in the UK for research power in medicine, health and life sciences.
REF 2021How our research is structured
Departments
The UCL Cancer Institute in the Faculty of Medical Sciences draws together over 400 scientists working together to develop world-class basic and translational cancer research.
Centres and Networks
The UCL Cancer Institute collaborates with specialist centres and other UCL divisions and departments to enhance our research and partnerships.
Translational Technology Platforms
The Translational Technology Platforms (TTPs) provide scientific infrastructure for cutting edge basic, translational and clinical cancer services to support cancer researchers at UCL.
Support for career development awards / fellowships
The UK has a flourishing landscape of Career Development Awards / Fellowships for talented junior scientists to set up their independent research laboratories. Theses include awards from UKRI, ERC, the Welcome Trust, Cancer Research UK, the Royal Society and many other organisations.
The UCL Cancer Institute has been very successful in supporting scientists for such awards. We provide a welcoming environment, extensive help for preparation of proposals, mock interviews and administrative support. Many of our fellows have also gone on to tenured positions.
Interested in exploring the UCL Cancer Institute as your host institution?
Please send a CV, a summary of your future plans, and a brief explanation of why you would like to be hosted at the UCL Cancer Institute for your fellowship. This should reach us at least 3 months before the funder's application deadline.
A selection committee of at least 3 UCL Cancer Institute personnel with suitable expertise will review the proposal and its suitability for shortlisting. Shortlisted applicants will be invited to visit us and make a presentation.
The same procedure applies to internal and external candidates.
UCL Cancer Institute
Click to email. CI.ECRhost.enquiries@ucl.ac.uk
Best Medicine
UCL Cancer Institute's Dr Claire Roddie on BBC Radio 4
Dr Claire Roddie joins comedian Kiri Pritchard-McLean to make the case for CAR-T cells being "the best medicine". Clare talks about programming immune cells to fight cancer.
Listen to the episode
